Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma

被引:109
|
作者
Olsen, SH [1 ]
Thomas, DG [1 ]
Lucas, DR [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
关键词
immunohistochemistry; cluster analysis; tissue microarray; sarcoma;
D O I
10.1038/modpathol.3800569
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
As a result of overlapping morphologic and immunohistochemical features, it can be difficult to distinguish synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma/primitive neuroectodermal tumor in core biopsies. To analyze and compare immunohistochemical profiles, we stained tissue microarrays of 23 synovial sarcomas, 23 malignant peripheral nerve sheath tumors, and 27 Ewing sarcomas with 22 antibodies potentially useful in the differential diagnosis, and analyzed the data with cluster analysis. Stain intensity was scored as none, weak, or strong. For CD99, tumors with membranous accentuation were independently categorized. Cluster analysis sorted five groups, with like tumors clustering together. Synovial sarcoma clustered into two groups: one cytokeratin and EMA positive ( n = 11), the other mostly cytokeratin negative, EMA positive, bcl-2 positive and mostly CD56 positive ( n 9). Malignant peripheral nerve sheath tumor clustered into two groups: one S100 positive, with nestin and NGFR positivity in most ( n 10), the other mostly S100 negative, and variably but mostly weakly positive for nestin and NGFR ( n 11). Ewing sarcomas clustered into a single group driven by membranous CD99 staining. Thirteen cases failed to cluster (outliers), while three Ewing sarcomas clustered into groups of other tumor types. Paired antibodies for each tumor type determined by visual assessment of cluster analysis data and statistical calculations of specificity, sensitivity, and predictive values showed that EMA/CK7 for synovial sarcoma, nestin/S100 for malignant peripheral nerve sheath tumor, and membranous CD99/Fli-1 for Ewing sarcoma yielded high specificity and positive predictive values. Cluster analysis also highlighted aberrant staining reactions and diagnostic pitfalls in these tumors. Hierarchical cluster analysis is an effective method for analyzing high-volume immunohistochemical data.
引用
收藏
页码:659 / 668
页数:10
相关论文
共 50 条
  • [21] Differential immunohistochemical expression of SLUG and ALDH1 in malignant peripheral nerve sheath tumour (MPNST) and monophasic synovial sarcoma (MSS)
    Kavuncuoglu, A.
    Kosemehmetoglu, K.
    VIRCHOWS ARCHIV, 2021, 479 : S166 - S166
  • [22] Utility of cytokeratin (CK) subsets in distinguishing monophasic synovial sarcoma (MSS) from malignant peripheral nerve sheath tumor (MPNST)
    Smith, TA
    Machen, SK
    Fisher, C
    Goldblum, JR
    MODERN PATHOLOGY, 1998, 11 (01) : 15A - 15A
  • [23] Utility of cytokeratin (CK) subsets in distinguishing monophasic synovial sarcoma (MSS) from malignant peripheral nerve sheath tumor (MPNST)
    Smith, TA
    Machen, SK
    Fisher, C
    Goldblum, JR
    LABORATORY INVESTIGATION, 1998, 78 (01) : 15A - 15A
  • [24] A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
    D'Adamo, David R.
    Dickson, Mark A.
    Keohan, Mary L.
    Carvajal, Richard D.
    Hensley, Martee L.
    Hirst, Catherine M.
    Ezeoke, Marietta O.
    Ahn, Linda
    Qin, Li-Xuan
    Antonescu, Cristina R.
    Lefkowitz, Robert A.
    Maki, Robert G.
    Schwartz, Gary K.
    Tap, William D.
    ONCOLOGIST, 2019, 24 (06): : 857 - 863
  • [25] Clear cell sarcoma mimicking peripheral nerve sheath tumor
    Schnarkowski, P
    Peterfy, CG
    Johnston, JO
    Weidner, N
    SKELETAL RADIOLOGY, 1996, 25 (02) : 197 - 200
  • [26] PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour
    Kang, Gu Hyun
    Kim, Kyoung-Mee
    Park, Cheol Keun
    Kang, Dae Young
    HISTOPATHOLOGY, 2009, 55 (03) : 368 - 369
  • [27] ADRENAL SPINDLE-CELL SARCOMA WITH FEATURES OF MALIGNANT PERIPHERAL-NERVE SHEATH TUMOR
    HARACH, HR
    LAIDLER, P
    ENDOCRINE PATHOLOGY, 1993, 4 (04) : 222 - 225
  • [28] Poorly differentiated synovial sarcoma - Immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors
    Folpe, AL
    Schmidt, RA
    Chapman, D
    Gown, AM
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (06) : 673 - 682
  • [29] Molecular and gene array analyses of rare pediatric mesenchymal tumors: malignant intracranial ectomesenchymoma compared to rhabdomyosarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma
    Kleinschmidt-DeMasters, Bette K.
    Lovell, Mark A.
    Donson, Andrew M.
    Wilkinson, C. Corbett
    Addo-Yobo, Steven
    Lillehei, Kevin
    Foreman, Nicholas K.
    FASEB JOURNAL, 2007, 21 (05): : A27 - A27
  • [30] Molecular and gene array analyses of rare pediatric mesenchymal tumors: malignant intracranial ectomesenchymoma compared to rhabdomyosarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma
    Kleinschmidt-DeMasters, Bette K.
    Lovell, Mark A.
    Donson, Andrew M.
    Wilkinson, C. Corbett
    Addo-Yobo, Steven O.
    Lillehei, Kevin O.
    Foreman, Nicholas K.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2007, 66 (05): : 428 - 428